ETON - Eton Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ETON is currently covered by 1 analysts with an average price target of $35.13. This is a potential upside of $18.34 (109.23%) from yesterday's end of day stock price of $16.79.

Eton Pharmaceuticals's activity chart (see below) currently has 4 price targets and 12 ratings on display. The stock rating distribution of ETON is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.89% with an average time for these price targets to be met of 679 days.

Highest price target for ETON is $33, Lowest price target is $33, average price target is $33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 22-Jan-2025. First documented stock forecast 10-Jun-2019.

Best performing analysts who are covering ETON - Eton Pharmaceuticals:

Raghuram Selvaraju

Currently out of the existing stock ratings of ETON, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$16.21 (96.55%)

$17

3 months 18 days ago
(22-Jan-2025)

8/9 (88.89%)

$18.34 (125.10%)

679

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ETON (Eton Pharmaceuticals) average time for price targets to be met?

On average it took 679 days on average for the stock forecasts to be realized with a an average price target met ratio 88.89

Which analyst has the current highest performing score on ETON (Eton Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on ETON (Eton Pharmaceuticals)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on ETON

Which analyst is the currently most bullish on ETON (Eton Pharmaceuticals)?

Raghuram Selvaraju with highest potential upside - $16.21

Eton Pharmaceuticals in the News

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2025 financial results on Tuesday, May 13, 2025. Management will host a conference call and live...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?